Utilization and Potential of RNA-Based Therapies in Cardiovascular Disease
Summary: Cardiovascular disease (CVD) remains the largest cause of mortality worldwide. The development of new effective therapeutics is a major unmet need. The current review focuses broadly on the concept of nucleic acid (NA)–based therapies, considering the use of various forms of NAs, including...
Main Authors: | Emma Louise Robinson, MS, PhD, J. David Port, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | JACC: Basic to Translational Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452302X22000389 |
Similar Items
-
The Landscape of Noncoding RNA in Pulmonary Hypertension
by: Lin Deng, et al.
Published: (2022-06-01) -
TREAT: Therapeutic RNAs exploration inspired by artificial intelligence technology
by: Yufan Luo, et al.
Published: (2022-01-01) -
How RNA catalyzes cyclization
by: Zhong, Zhensheng, et al.
Published: (2018) -
Revealing Landscape of Competing Endogenous RNA Networks in Sepsis-Induced Cardiovascular Diseases
by: Wei Xiong, et al.
Published: (2023-07-01) -
From Molecular Mechanisms to Therapeutics: Understanding MicroRNA-21 in Cancer
by: Jiho Rhim, et al.
Published: (2022-09-01)